| Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis MA Zocco, LZ Dal Verme, F Cremonini, AC Piscaglia, EC Nista, ... Alimentary pharmacology & therapeutics 23 (11), 1567-1574, 2006 | 660 | 2006 |
| The effect of oral administration of Lactobacillus GG on antibiotic‐associated gastrointestinal side‐effects during Helicobacter pylori eradication therapy A Armuzzi, F Cremonini, F Bartolozzi, F Canducci, M Candelli, V Ojetti, ... Alimentary pharmacology & therapeutics 15 (2), 163-169, 2001 | 482 | 2001 |
| The role of intestinal microbiota and the immune system. F Purchiaroni, A Tortora, M Gabrielli, F Bertucci, G Gigante, G Ianiro, ... European Review for Medical & Pharmacological Sciences 17 (3), 2013 | 423 | 2013 |
| Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study A Armuzzi, F Cremonini, V Ojetti, F Bartolozzi, F Canducci, M Candelli, ... Digestion 63 (1), 1-7, 2001 | 295 | 2001 |
| Small intestinal bacterial overgrowth: diagnosis and treatment A Gasbarrini, EC Lauritano, M Gabrielli, E Scarpellini, A Lupascu, V Ojetti, ... Digestive diseases 25 (3), 237-240, 2007 | 254 | 2007 |
| Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria CD Campli, A Gasbarrini, E Nucera, F Franceschi, V Ojetti, ES Torre, ... Digestive diseases and sciences 43, 1226-1229, 1998 | 236 | 1998 |
| Extradigestive manifestations of Helicobacter pylori gastric infection A Gasbarrini, F Franceschi, A Armuzzi, V Ojetti, M Candelli, ES Torre, ... Gut 45 (suppl 1), I9-I12, 1999 | 196 | 1999 |
| Guidelines for the management of Helicobacter pylori infection in Italy: the III Working Group Consensus Report 2015 RM Zagari, M Romano, V Ojetti, R Stockbrugger, S Gullini, B Annibale, ... Digestive and Liver Disease 47 (11), 903-912, 2015 | 175 | 2015 |
| High prevalence of celiac disease in patients with lactose intolerance V Ojetti, G Nucera, A Migneco, M Gabrielli, C Lauritano, S Danese, ... Digestion 71 (2), 106-110, 2005 | 170 | 2005 |
| Beneficial effects of Helicobacter pylori eradication on migraine. A Gasbarrini, A De Luca, G Fiore, M Gambrielli, F Franceschi, V Ojetti, ... Hepato-gastroenterology 45 (21), 765-770, 1998 | 166 | 1998 |
| Predicting intensive care unit admission and death for COVID-19 patients in the emergency department using early warning scores M Covino, C Sandroni, M Santoro, L Sabia, B Simeoni, MG Bocci, V Ojetti, ... Resuscitation 156, 84-91, 2020 | 158 | 2020 |
| Clinical characteristics and prognostic factors in COVID‐19 patients aged≥ 80 years M Covino, G De Matteis, M Santoro, L Sabia, B Simeoni, M Candelli, ... Geriatrics & gerontology international 20 (7), 704-708, 2020 | 158 | 2020 |
| Interaction between lipopolysaccharide and gut microbiota in inflammatory bowel diseases M Candelli, L Franza, G Pignataro, V Ojetti, M Covino, A Piccioni, ... International journal of molecular sciences 22 (12), 6242, 2021 | 157 | 2021 |
| Lactose intolerance: from diagnosis to correct management. T Di Rienzo, G D'angelo, F D'aversa, MC Campanale, V Cesario, ... European Review for Medical & Pharmacological Sciences 17, 2013 | 153 | 2013 |
| Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication EC Nista, M Candelli, MA Zocco, F Cremonini, V Ojetti, R Finizio, C Spada, ... Official journal of the American College of Gastroenterology| ACG 101 (9 …, 2006 | 153 | 2006 |
| The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial V Ojetti, G Ianiro, A Tortora, G D’Angelo, TA Di Rienzo, S Bibbò, ... J Gastrointestin Liver Dis 23 (4), 387-91, 2014 | 151 | 2014 |
| Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed? E Scarpellini, V Valenza, M Gabrielli, EC Lauritano, G Perotti, G Merra, ... Official journal of the American College of Gastroenterology| ACG 105 (2 …, 2010 | 150 | 2010 |
| Levofloxacin‐based triple therapy vs. quadruple therapy in second‐line Helicobacter pylori treatment: a randomized trial EC Nista, M Candelli, F Cremonini, IA Cazzato, S Di Caro, M Gabrielli, ... Alimentary pharmacology & therapeutics 18 (6), 627-633, 2003 | 147 | 2003 |
| Impact of Lactobacillus reuteri Supplementation on Anti‐Helicobacter pylori Levofloxacin‐Based Second‐Line Therapy V Ojetti, G Bruno, ME Ainora, G Gigante, G Rizzo, D Roccarina, ... Gastroenterology research and practice 2012 (1), 740381, 2012 | 146 | 2012 |
| Physiology and pathophysiology of liver lipid metabolism FR Ponziani, S Pecere, A Gasbarrini, V Ojetti Expert review of gastroenterology & hepatology 9 (8), 1055-1067, 2015 | 141 | 2015 |
